Home/ExThera Medical/Michael DiMeo

MD

Michael DiMeo

Chief Financial Officer

ExThera Medical

Therapeutic Areas

Infectious Disease Oncology

ExThera Medical Pipeline

Drug	Indication	Phase
Seraph 100	Bloodstream Infections (e.g., Sepsis, COVID-19)	Phase 2/3
ONCObind	Metastatic Cancer (e.g., Pancreatic Cancer)	Phase 1

Leadership Team at ExThera Medical

Chairman and President

Chief Executive Officer

VP of R&D and Chief Science Officer

Chief Medical Officer

View full ExThera Medical profile